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CHAPTER 1: PHANTOM LIMB PAIN
History
In 1536, a man named Ambroise Paré joined the French army as a surgeon. He
became a leading pioneer of surgery, specifically amputation (Axoiti, Geramani, Sarbu,
& Karamanou, 2014). During the mid-sixteenth century, deep gunshot wounds would
lead to gangrene. Because of this, amputation was necessary. At the time, cauterizing the
wound was the most widespread way to stop the bleeding, but Paré looked for more
effective, less painful methods. Paré began to use ligatures, silk thread, to tie around the
blood vessels to stop the bleeding. However, at the time, this process was too slow and
ineffective due to the lack of antiseptics. During his time as a military surgeon, it is
believed that Paré was the first to report and write about amputee soldiers that were still
cognizant of their missing limb (Richardson, 2010). The first time that Paré describes the
syndrome is in The Method of Treating Wounds Made by Harquebuses and Other Guns),
Paré portrays the syndrome as well as provides multiple different models for such pain
(L. Nikolajsen & Jensen, 2001). In Chapter 23 of his complete works, Paré writes, “The
patients imagine they have their members yet entire, and yet doe complain thereof (which
I imagine come to pass, for that, the cut nerves retire themselves towards their original,
and thereby cause a pain like to convulsions)” (Paré, 1575, as cited in Finger & Hustwit,
2003, p. 677) In other words, Paré describes that the individual has a painful sensation as
though their whole limb is still intact. He then continues that he believes the cut nerve is
the reason for this pain. In this quote, it can be seen that Paré hypothesizes that the
painful sensation (phantom limb) comes from the nerve being cut during amputation.
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After Paré, others began to describe this pain in missing limbs. In 1830, Charles
Bell published a monograph called The Nervous System of the Human Body. This
monograph serves as the first descriptor of several different neurological disorders. In it,
Bell describes an amputee who still has phantom limb pain and the perception of motion.
Bell theorizes that the reason for this phantom limb is “muscular sense,” a term that he
had already coined (Furukawa, 1990). In this, Bell describes how individuals know where
their muscles are without the need for touch, and this is the reason that phantom limb
pain exists. Bell’s understanding of muscular sense is similar to our current view of
proprioception. Currently, proprioception has a similar definition in that proprioception is
the ability to understand the location of our body parts in regards to other parts, including
body equilibrium and balance. Magendie (1833), Rhone (1842), and Gueniot (1862) also
provided detailed descriptions of phantom limb (L. Nikolajsen & Jensen, 2001).
In 1866, a Civil War surgeon named Silas Weir Mitchell published a piece in The
Atlantic Monthly. The article called “The Case of George Dedlow” describes a surgeon
whose training is interrupted by entering the Union Army as an infantry officer (Mitchell,
1866). During his time in the army, George Dedlow loses all four of his limbs to
amputation. The story goes on to discuss a head and trunk who still feel sensations of the
missing limbs. The work of Mitchell is of particular interest to scientists because of its
accurate depiction of the neurological issues such as these phantom sensations (Canale,
2004). This story made a large impact on the general public because of this depiction as
well as the ending in which it describes a séance in which Dedlow is reunited with his
legs. At the beginning of the article, Mitchell (2004) says “I ought to add, that a good
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deal of what is here related is not of any scientific value whatsoever,” (p. 113). Even with
this statement, the article had a large impact on the public perception of amputation.
It is Silas Weir Mitchell who was the first to attribute the term “phantom” to these
sensations that he describes in the “The Case of George Dedlow” (Richardson, 2010).
Furthermore, Mitchell coined the term phantom limb pain, what these sensations are
called now. In 1872, Mitchell discusses the phenomenon in a scientific manner in his
book Injuries of the Nerves and their Consequences. In the chapter “Neural Maladies of
Stumps,” Mitchell gives case examples of the physiology of the stump and the sensory
hallucinations that come with it (Mitchell, 1872). In his book he states, “Among ninety
cases, including a great variety of amputations, I have found but four cases—two of an
arm, the others of legs—in which there never had been delusion as to the presence of the
absent member,” (Mitchell, 1970, p. 348). He goes on to discuss the faradization of the
stump of an arm, which produces a feeling in the hand. Faradization is the stimulation of
the stump of the arm with electrical current. In his account, Mitchell is describing what
we have come to know as phantom sensations. Mitchell describes the sensory
impressions behind such a feeling, and as such, defines his own version of why he
believes phantom limb sensation exists.
Reports on this pain continued into modern times due to amputations in World
War I, World War II, the Vietnam War, and the Israeli war (Edwards, Mayhew, & Rice,
2014; Foote, Kinnon, Robbins, Pessagno, & Portner, 2015; Heszlein-Lossius et al., 2018;
Machin & Williams, 1998). Continued research investigated other reasons for amputation
such as peripheral vascular disease (commonly due to arteriosclerosis and neoplasms
3

(benign or malignant growths; L. Nikolajsen & Jensen, 2001). During this time, it was
believed that phantom limb pain existed in a small subset of individuals and early
research showed the incidence of such pain to be around 4% (Henderson & Smyth,
1948). At this time, phantom limb pain was measured by whether a patient asked for pain
medication or not, and this is most likely the reason why newer research has found a
higher percentage for the incidences of pain (L. Nikolajsen & Jensen, 2001).
From Paré’s time in 1536, a number of hypotheses and theories have been
developed in order to explain this phantom limb pain (Finger & Hustwit, 2003). Bell used
“muscular sense” to explain the pain, while Mitchell, describes it as being due to sensory
impressions. Even with the identification of the disorder such a long time ago, the
neurological phenomenon of phantom limb pain and the mechanisms behind it are still
not fully understood (Flor, Nikolajsen, & Jensen, 2006).
Phantom Limb Prevalence and Variances
Before beginning a discussion behind the etiology of phantom limb pain, it is
important to differentiate it from phantom sensations and residual limb pain (or stump
pain). Phantom limb sensation is any sensation felt in the amputated limb that is not pain.
Residual limb pain is any pain felt in the stump of the amputated limb (Ahmed et al.,
2017). Phantom limb pain is a painful sensation in reference to the missing limb. This
pain can begin as early as right after the removal of the limb, and can be described as any
combination of the following descriptors: “stinging, cutting, piercing, radiating, tight,
nagging, squeezing, tingling, and shocking” (Ehde et al., 2000, p. 1040). While phantom
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limb pain is normally thought of as pain to an amputated limb, this pain can be found
from removing other parts of the body. Examples include, but are not limited to pain in
removed teeth, genital organs, bladder and breasts (Woodhouse, 2005). Even though it is
not uncommon for phantom limb pain to occur in these areas, most research on phantom
limb pain is focused on amputated limbs.
There is a large amount of variation within phantom limb pain among individuals
with amputations. Such variation can be found in the intensity and duration of the pain.
For most individuals, the phantom limb pain is episodic and is not constant (Whyte &
Niven, 2001). On a scale of 0 (no pain) to 10 (pain as bad as it could be), an average pain
score of 5.1 was found (Ehde et al., 2000). It is important to note that the standard
deviation was 2.6, showing that there is large individual variability in the intensity of the
pain. Furthermore, in this same study, when looking at the duration of the pain, over half
of the individuals reported their pain only lasting a few minutes (52%), while others
reported periods of an hour (26%). While there is variation in the episodes of phantom
limb pain, there seems to be no difference in reports of phantom limb pain in regards to if
the limb is an upper or lower extremity (Poor Zamany Nejat Kermany, Modirian,
Soroush, Masoumi, & Hosseini, 2008).
There are also variations in when phantom limb pain first occurs, and how outside
variables can impact the incidence of it. Jensen, Krebs, Nielsen, & Rasmussen (1983)
found that 47 percent of individuals had pain in the first 24 hours following amputation.
This number grew to 84 percent eight days post-operation, and 90 percent after six
months (T. S. Jensen et al., 1983). A study by Ehde et al. (2000) reported a slightly
5

smaller number of 72 percent of individuals had phantom pain within six months of their
amputation. That is to say that roughly half of the individuals first experience phantom
limb pain within a day, but the onset can still occur up to six months following
amputation. Additionally, it has been shown that environmental factors can increase the
incidence of pain. Environmental factors such as pre-amputation pain, smoking after
proximal level of amputation, and postoperative analgesia have all be found to increase
pain levels (Ahmed et al., 2017; Yin et al., 2017). On the other hand, presurgical
interventions such as perioperative epidural blockade do not seem to prevent the onset of
phantom limb pain (Nikolajsen, Ilkjaer, Christensen, Krøner, & Jensen, 1997).
Theories Behind Phantom Limb Pain
Just like the variance within the pain itself, there are variations in the theories
describing phantom limb pain. The neurological mechanism of phantom limb pain is still
unknown. At first, theories revolving around phantom limb pain were psychological in
nature, but now there is increasing evidence that the pain is neurological in nature (Flor et
al., 2006; Raffin, Richard, Giraux, & Reilly, 2016; Seo et al., 2017). Three main theories
have been implicated in phantom limb pain and involve the peripheral nervous system,
the central nervous system, and body schema.
Peripheral nervous system.
The peripheral nervous system includes all parts of the nervous system except for
the brain and spinal cord. A study done by Zeng, Wang, Guo, He, & Ni (2016) showed
similar results when performing neuroma infiltrations, only the pain in the stump was
6

reduced. They had different results when performing a nerve block. In this study, a
femoral and sciatic nerve block was performed and the result was longer pain relief.
There was an 80% pain reduction in both stump pain and phantom limb pain that lasted
40 hours for the subject (Zeng et al., 2016). This study was only a case report, and
because of this, the effect of targeting of the femoral and sciatic nerves might be different
with a larger subject pool, or the results may vary with an upper extremity.
With this being said, intravenous regional anesthesia has been noted to give rise to
phantom limb pain in individuals without amputation (Dominguez, 2001; Paqueron,
Lauwick, Le Guen, & Coriat, 2004). Reports have been given where the body part feels
like a phantom and is stuck in one position until intravenous regional anesthesia is
stopped. It should be noted, that intravenous regional anesthesia does not normally have
this effect on individuals. Still, these reports show that the peripheral nervous system
might have a larger effect on phantom limb pain than previously thought.
Other theories that pinpoint the peripheral nervous system as the reason behind
the pain focus on spinal nerves. There are two roots leading into/out of the spinal cord,
the dorsal root and the ventral root. The dorsal root is responsible for the afferent, or
incoming, sensory information; whereas the ventral root is responsible for the efferent, or
outgoing, motor information. In a study by Vaso et al. (2014), they suggest that phantom
limb pain is caused by an increased input from afferent sensory inputs to the dorsal root
ganglion. This increased sensory input is due to axotomized (cut axons of) neurons
during amputation. In their study, an intraforaminal block almost completely reduced
phantom limb pain in their subjects, suggesting that the dorsal root ganglion is the
7

spontaneous generator of a phantom limb. In this study, they only blocked one root, while
multiple roots innervate the leg for sensory stimulation. The exact reason for why it still
provided relief is unknown, but it could be because the majority of cases with phantom
limb experience the pain in the foot, and this was the root that was blocked.
Even with all of this evidence, most have abandoned peripheral nervous system
theories due to the fact that phantom limb pain frequently persists despite neuroma
infiltration and nerve/plexus block (Birbaumer et al., 1997). These types of treatment
tend to alleviate stump pain, but not phantom limb pain. Therefore, a large proportion of
phantom limb pain research has since been directed on the origin of phantom limb pain
being in the central nervous system.
In summary, while research has been steering away from the peripheral nervous
system for answers with regard to phantom limb pain, it seems to still have some
involvement. It is now known that the involvement is not directly at the site of the
neuroma but may be higher up along the peripheral nervous system. This could mean
increased activity at the spinal nerves themselves (as seen by the femoral and sciatic
nerve blocks) or even as high up as the dorsal roots.
Central nervous system.
The central nervous system contains the brain and the spinal cord. Phantom limb
pain theories that involve the central nervous system identify maladaptive brain plasticity
as the cause (Birbaumer et al., 1997; Flor et al., 2006). There are multiple locations in
which this brain plasticity begins to take place. They include the primary somatosensory
8

cortex (postcentral gyrus), the primary motor cortex (precentral gyrus), and within
commissural fibers (connecting the two hemispheres of the brain).
Within the somatosensory strip, certain areas are devoted to certain body parts.
This is often described as a homunculus (Snyder & Whitaker, 2013). This image depicts
both the somatosensory and motor strips and shows what area of each strip is devoted to
what body part. When a limb is amputated, this cortical organization begins to restructure
(de Klerk, Johnson, & Southgate, 2015). When the trunk or face is stimulated on the
ipsilateral side of the amputation, phantom limb sensations can be evoked (Knecht et al.,
1996). The trunk and the face are the two regions that are next to the arm on the
homunculus. Moreover, when assessed with MRI imaging, the cortical region for the
limb is also evoked when the trunk or face is stimulated (Knecht et al., 1996). This
sensation is not limited to just the ipsilateral side though, as contralateral stimulation also
causes some sensation and because of this, interhemispheric structures must also be
involved. Additionally, artificial stimulation can be engineered in humans (Lee et al.,
2018). In a study by Lee et al. (2018), they stimulated the cortex with subdural minielectrocorticography grids. In doing so, they were able to induce artificial somatization
during a behavioral task. By varying parameters such as increased pulse width, current
strength, and frequency, they increased such sensations. With this being said, the cortical
structure for the area is still relatively intact and resembles closely to that of a normal
cortex (Björkman et al., 2012). In the study by Bjorkman et al (2012) they demonstrate
through functional magnetic resonance imaging that when the stump is stimulated the
area that used to contain sensory information for the fingers is still being stimulated. This
9

means that although there is somatosensory cortex restructuring in people with
amputations, this restructuring is not complete.
These maladaptive changes can also be found in the primary motor cortex in
comparing individuals with hand amputation to healthy individuals (Raffin et al., 2016).
This theory proposes that due to lack of stimulation in these areas, restructuring begins to
take place. In particular, this causes the primary motor cortex to reorganize itself to
utilize the under-stimulated area. In the study done by Raffin et al (2016), through
functional magnetic resonance imaging, they found asymmetries between hemispheres
for upper limb amputees. Specifically, there was a difference in the lip and elbow areas,
but not the hand representation. This means that there was cortical reorganization in the
areas surrounding the hand, where the pain was felt, but no reorganization of the had area
itself. Furthermore, the less control that the individual had over their phantom limb, the
more restructuration had taken place. On the contrary, if the individuals felt that they
could move their phantom hand, they had less topographic changes in the lip and elbow
areas (Raffin et al., 2016). More topographic changes led to higher intensity of their
phantom pain. This adds to the complexity of what mechanisms are forcing the cortical
reorganization.
Returning to the idea that there are changes in bilateral mechanisms, it can be
seen that interhemispheric interactions are also changed after amputation. It has been
found that there are microstructural changes in the white matter tracts of commissural
fibers connecting the premotor cortices (Jiang et al., 2015). This means that the cortical
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restructuring is not limited to just the side that contains information for processing the
amputations (contralateral), but the opposite side as well.
To summarize, central nervous system maladaptive plasticity is one of the leading
theories in regard to phantom limb pain. Changes in the connections of the brain have
been seen in the somatosensory strip, the motor strip, as well as interhemispheric
structures. While these theories do a good job of explaining the overall sensation, they do
not discuss at what point these sensations transform into pain and what causes this change
to take place.
Body schema.
A third theory implements the idea of body schema. Body schema is an internal
awareness of an individual’s body and the relationship between body parts. This theory
relates most closely to that of the previous theory involving the central nervous system
and should be regarded as an expansion on it. In this theory, there is the belief that there
is no afferent signaling from the limb, but the central nervous system still believes there
is based on the neurocircuitry still present (Jerath, Crawford, & Jensen, 2015). Such
locations of spatial processing could include the parietal lobe. A large amount of work
done on the body schema theory is theoretical, and few studies have been done proving
its significance.
Relief from phantom limb pain can also implicate the body schema theory. One
study describes a case in which scratching and touching another person’s body or one’s
own prostheses was helpful in relieving pain which may provide further support for the
11

idea of body schema and image (Weeks & Tsao, 2010). This study was only a case
report, but this report implies the potential involvement of the visual system in phantom
limb pain.
The rubber hand paradigm is further support for the body schema theory. In the
paradigm, one believes that the touch that is applied to rubber hand is actually taking part
in one’s own body (Botvinick & Cohen, 1998). This is due to the simultaneous
stimulation of one’s own hand, while also committing visual feedback to the hand itself.
The brain integrates these two events into a single event in which its own hand is being
touched (Metral, Gonthier, Luyat, & Guerraz, 2017). This illusion provides support to
why touching another person could relieve phantom limb pain and provides support to
the body schema theory. A theory that in regards to the phantom limb is mostly
theoretical.
Though body schema theory may be considered an extension of central nervous
system maladaptivity, this maladaptivity does not necessarily explain how the
involvement of other individual’s body parts can relieve phantom limb pain.
Conclusion
All of these models are conflicting both in theory and in data. At the same time, in
other places, these theories overlap with similar mechanisms and similar parts of the
nervous system being described. Still to this day, no exact neurological mechanism has
been found to fully explain phantom limb pain (Stockburger, Sadhir, & Omar, 2016).
Further research on phantom limb pain must be done in order to discover the true reason
12

behind it. The next chapter will examine the ways that we treat phantom limb pain, even
when so little is known about its cause.
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CHAPTER 2: TREATMENT OF PHANTOM LIMB PAIN
The following quotation comes from the book Phantoms in the Brain by
Ramachandran and Blakeslee (1998). Ramachandran was the first to invent and use
mirror therapy for the treatment of phantom limb pain:
“To enable patients like Irene to perceive real movement in their nonexistent
arms, we constructed a virtual reality box. The box is made by placing a vertical
mirror inside a cardboard box with its lid removed. The front of the box has two
holes in it, through which the patient inserts her “good hand” (say, the right one)
and her phantom hand (the left one). Since the mirror is in the middle of the box,
the right hand is now on the right side of the mirror and the phantom is on the left.
The patient is then asked to view the reflection of her normal hand in the mirror
and to move it around slightly until the reflection appears to be superimposed on
the felt position of her phantom hand. She has thus created the illusion of
observing two hands, when in fact she is only seeing the mirror reflection of her
intact hand. If she now sends motor commands to both arms to make mirror
symmetric movement as she was conducting an orchestra or clapping, she of
course “sees” her phantom moving as well. Her brain receives confirming visual
feedback that the phantom hand is moving correctly in response to her command”
(p. 46).
As discussed in the previous chapter, the mechanisms behind phantom limb pain
are poorly understood. Because of this, it makes sense then that the treatment options for
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phantom limb pain are just as variable in their mechanisms and effectiveness. In a survey
done on American Veterans over their chronic stump and phantom pain, only 1% of
participants reported a lasting relief of treatment (Sherman, Sherman, & Parker, 1984).
This survey demonstrates the ongoing challenge of the treatment of phantom limb pain.
This chapter will give an overview of the common treatment options for phantom limb
pain such as medication, injections, and more invasive interventions such as surgery. It
will then further explore the use of mirror therapy as a treatment. Mirror therapy is one
effective treatment for phantom limb pain, yet the reason why is not clear. This chapter
focus on its use in phantom limb pain, and potential mechanisms for why it is effective.
Treatment Options
Medications
Medications are a common treatment for phantom limb pain because they are
minimally invasive and are already prescribed for many types of pain (Everdingen,
Graeff, Jongen, Dijkstra, & Vissers, 2017; Moura et al., 2018). Some medications that are
used to treat phantom limb pain include opioids, NMDA receptor antagonists, nonsteroidal, anti-inflammatory drugs, anticonvulsants, and antidepressants (Alviar, Dungca,
& Hale, 2016).
Opioids work by mimicking endogenous enkephalins and endorphins. Opioids
bind onto the receptors for enkephalins and endorphins, modulating the body’s pain
response. Opioids are prescribed for a variety of chronic pain disorders, and this is why
they are prescribed for phantom limb pain as well. Opioids have been found to be an
15

effective treatment for relieving phantom limb pain symptoms (Alviar et al., 2016). This
effectiveness has been found for both oral and intravenous use of morphine for phantom
pain treatment (Huse, Larbig, Flor, & Birbaumer, 2001; C. L. Wu et al., 2002). Pain relief
when using morphine was found in up to fifty percent of patients with phantom limb pain
but was found to be more effective in relief for stump pain (C. L. Wu et al., 2002). Even
with the effectiveness of opioids in some individuals, common side effects of opioids
include tiredness, dizziness, sweating, constipation, urination difficulties, nausea, vertigo,
itching, and shortness of breath (Huse et al., 2001). Furthermore, opioid use carries a high
potential for addiction. This is particularly relevant for the veteran population who have a
high comorbidity of other psychiatric illnesses such as post-traumatic stress disorder
(PTSD; Wilder et al., 2016).
Another medication that has had found mixed results is NMDA receptor
antagonists. These drugs decrease the activity at certain receptors within the nervous
system, called NMDA receptors. Normally, these receptors cause hyperalgesia,
neuropathic pain, and reduced functionality of opioid receptors. In regards to a phantom
limb, these medications block the NMDA receptors in the dorsal horn of the spinal cord,
which are responsible for the majority of sensitization and hyperexcitability. There are
different types of these NMDA receptor antagonists, each of which shows differences in
effectiveness. For example, memantine has been shown to be no different than a placebo
in relieving phantom limb pain (Mair et al., 2003), whereas dextromethorphan has been
shown to increase pain relief up to fifty percent, and had very little side effects in the
study (Abraham, Marouani, Kollender, Meller, & Weinbroum, 2002). While it has been
16

found effective, the length of the study only showed short-term effectiveness, and
additional research is needed to validate their effectiveness over a longer duration.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used
treatment for phantom limb pain after opioids and acetaminophen (Hanley, Ehde,
Campbell, Osborn, & Smith, 2006). Typically, NSAIDs work as nonselective inhibitors
of the enzyme cyclooxygenase (COX) (Sukhtankar, Lee, & Rice, 2014). COX normally
catalyzes the formation of prostaglandins, a neurotransmitter that transmits pain. Over
20% of respondents to a survey of those with lower limb amputations responded that if
they were receiving treatment for phantom limb pain it was with NSAIDs (Hanley et al.,
2006). Even with the frequency of use, little research has been done on the effectiveness
of treatment of both acetaminophen and NSAIDs. In the same survey, over half of the
respondents using NSAIDS ranked their effectiveness as 1 or 2 on a scale of 1-5, which
represented very little relief as a result of the drug (Hanley et al., 2006). NSAIDs work by
inhibiting the enzymes needed to synthesize prostaglandin, a neurotransmitter that works
to increase pain. Acetaminophen has similar effectiveness reported as NSAIDs (Hanley et
al., 2006). The mechanism of action of acetaminophen is not fully understood, but it is
believed that it is a weak inhibitor of prostaglandins (similar to NSAIDs), with a different
mechanism of action (Sharma & Mehta, 2014). Though acetaminophen and NSAIDs are
commonly prescribed, there is little research other than self-report data on how effective
they are on relieving phantom limb pain.
Both anticonvulsants and antidepressants are medications that are normally used
to treat other disorders, seizures, and depression, respectively (Margolis, Chu, Want,
17

Copher, & Cavazos, 2014; Thase & Schwartz, 2015). Anticonvulsants increase the
activity of inhibitory neurotransmitters and therefore decrease the overall activity of the
central nervous system. By doing so, it is thought they can reduce pain, which is normally
transmitted through excitatory mechanisms, such as by the neurotransmitter glutamate.
Antidepressants typically increase the concentration of different neurotransmitters, such
as serotonin, within the central nervous system. While both of these medications are
sometimes prescribed for phantom limb pain, there is conflicting research supporting
their effectiveness. One study on the use of gabapentin (anticonvulsant) found the drug
effective in decreasing phantom limb pain intensity, while another found no difference
between gabapentin and a placebo (Bone, Critchley, & Buggy, 2002; D. G. Smith et al.,
2005). Due to the paucity of research on these types of drugs with respect to phantom
limb pain, it is difficult to support their use in the treatment of phantom limb pain. In
particular, these types of drugs may only be effective in a small group of individuals.
As outlined above, there are mixed results on how effective medications are in
treating phantom limb pain. It has been found that there is not one medication that
effectively relieves pain for all patients. Additionally, it should be noted that these
medications are not curing the basis of phantom limb pain, but only treating the
symptoms with varying degrees of success. These medications have a large number of
adverse side effects, and as such, they should only be used on a patient by patient basis.
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Noninvasive treatment
Noninvasive treatment options for phantom limb pain include nerve stimulation,
acupuncture, and mirror therapy (Mulvey et al., 2010; Trevelyan, Turner, SummerfieldMann, & Robinson, 2016; Young Kim & Young Kim, 2012). Mirror therapy will be
discussed in depth later in this chapter.
Transcutaneous electrical nerve stimulation (TENS) is a tool for pain management
that provides short-term relief for people with chronic pain. There are minor side effects
as compared to other treatments of phantom limb pain such as pharmacological
interventions. TENS units work to excite/stimulate sensory nerves through an electrical
current. In doing so, the unit activates natural pain relief mechanisms. It is believed that
the TENS units target two naturally occurring systems: the pain gate mechanism, and the
endogenous opioid system. The relationship between frequency and intensity of the
stimulation and the systems it interacts with, as well as its optimal pain-relieving
properties, is unclear (Köke et al., 2004). TENS has been found to be an effective
treatment of stump pain (Mulvey et al., 2010). In this same study, it was shown that
appropriate electrode placement could evoke TENS sensations in the phantom limb,
which relieved the pain of phantom limb (Mulvey et al., 2010). Additionally, research has
shown TENS to be an effective pain management tool for those with phantom limb pain
(Tilak et al., 2016). It should be noted, however, that the use of TENS does not provide
long-lasting effects on the pain.
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It is believed that acupuncture has a similar mechanism of action as TENS in that
it activates the endogenous opioid system in order to provide pain relief (Housley, 2016).
Acupuncture involves inserting very thin needles into the skin at strategic points around
the body. The research done on acupuncture and its effects on phantom limb pain are
small, coming mostly from case studies and trials. In one such small trial, acupuncture
was shown to be effective in relieving the maximum intensity of phantom limb pain as
well as average pain intensity (Trevelyan et al., 2016). Some participants received
acupuncture in the affected limb, some received it in the contralateral limb, and some
received it in both. While such results are exciting, it is clear that further research needs
to be done in order to determine if acupuncture is effective in treating phantom limb pain,
and which location among these works the best.
Noninvasive treatments are a promising area of investigation in the treatment of
phantom limb pain and will be explored further later in this chapter. With this being said,
there is a lack of knowledge on the exact mechanism of action of these treatments in
chronic pain, and particularly in, phantom limb pain.
Minimally invasive treatment
Minimally invasive treatment options for phantom limb pain consist of spinal
cord stimulation and injections. In a spinal cord stimulation, through surgery, a spinal
cord stimulator is placed under the skin and a wire sends a mild electrical current to the
spinal cord (Eldabe et al., 2015). The electrodes are placed in the dorsal epidural space.
This is the space above the dura of the spinal cord and below the bone of the vertebrae.
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When the device is turned on, it stimulates the fibers around the area of the spinal cord
that is responsible for where the pain is felt. While the mechanism of action of spinal
cord stimulation is not known, it is proposed to do with either altering the chemical
transmission of the dorsal root of the spinal cord, or through the activation of dorsal
column nuclei (Smits, Van Kleef, Holsheimer, & Joosten, 2013). When looking at
phantom limb pain, spinal cord stimulation has mixed results (McAuley, Van Gröningen,
& Green, 2013; Viswanathan, Phan, & Burton, 2010). While patients received the initial
benefit of pain relief from the insertion of the device, one year and two years following
the insertion the relief was not as strong (McAuley et al., 2013). Side effects found in
phantom limb patients with the insertion of the spinal cord stimulator included allergic
dermatitis to the generator and surgical site infection (Viswanathan et al., 2010). Both of
these studies were conducted with small sample sizes, and because of this further
research is needed in order to understand if this treatment should be prescribed to patients
experiencing phantom limb pain.
Injections for phantom limb pain work on both the musculoskeletal system and
the peripheral system. Examples of relief include bupivacaine and lidocaine injections
which are called nerve blocks. These nerve blocks work by blocking the pain signaling of
the nerves that innervated the limb. When looking at bupivacaine injections, a small
study showed relief in phantom limb pain in six out of eight patients (Casale, Damiani, &
Rosati, 2009). Because this was a small study, further research must be done to determine
bupivacaine’s effectiveness. The effectiveness of lidocaine on phantom limb pain has
been examined in injections that also contained Depo-Medrol. Depo-Medrol
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(methylprednisolone acetate) is a steroid that works on the musculoskeletal system in
order to relieve inflammation. This study also examined how injections of botulinum
toxin type A could be used to treat phantom limb pain. In this study, it was found that
botulinum toxin type A and lidocaine/Depo-Medrol had nearly equal relief of residual
limb pain (stump pain), but did not work on phantom limb pain (Wu, Sultana, Taylor, &
Szabo, 2012). While these injections are used in an attempt to target phantom limb pain,
it seems they have better effectiveness in the relief of stump pain.
Minimally invasive treatments have mixed results in the treatment of phantom
limb pain. Both spinal cord stimulation and injections can be seen as an effective
treatment for relieving stump pain after amputation. They do not, however, seem to be
effective in the treatment of phantom limb pain. Even though studies done on this
subtype of treatment are all small studies, their results do not show much promise as a
treatment.
Invasive treatment
Invasive treatment for phantom limb pain includes deep brain stimulation and
stump revision. These surgeries are intensive and can potentially lead to a large number
of side effects.
Stump revision therapy is normally done to facilitate the fitting of a prosthesis
and/or treatment of a neuroma (Tintle, Baechler, Nanos, Forsberg, & Potter, 2012).
Stump revision for a prosthesis can be due to skin scarring, the shape of the bone(s), or
chronic ulcers that inhibit the prosthesis from fitting correctly. On the other hand, a
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neuroma is a benign growth of nervous system tissue which occurs after irritation or
injury (amputation in this case). Neuromas typically cause a painful sensation wherever
they are located. While neuromas are painful, they are not the only source of stump pain,
and phantom limb pain can exist with or without a neuroma (Zeng et al., 2016).
Normally, stump revision is not carried out just for the treatment of phantom limb pain.
The success rate for stump revision is very high when there is a known cause for the pain
(normally stump pain), but on the flip side is very low when there is no known cause and
for this reason it is not typically performed only for phantom limb pain (Tintle et al.,
2012). With any surgery, there is the risk of complication such as infection. For these
reasons, there is very little research on stump revision’s effect on phantom limb pain.
Deep brain stimulation involves the placement of electrodes deep within the brain.
These electrodes provide an electrical stimulus to certain areas of the brain and either
regulate abnormal activity (similar to a pacemaker) or are targeting certain cells to trigger
the release of specific neurotransmitters (Farrell, Green, & Aziz, 2018). Deep brain
stimulation is used to treat neurological disorders such as Parkinson’s disease, Tourette
syndrome, and chronic pain (Daneshzand, Faezipour, & Barkana, 2018; Farrell et al.,
2018; Smeets et al., 2018). In the treatment of chronic pain, deep brain stimulation is
successful in cases where other treatments such as medications and other more
conservative measures have proved unsuccessful (Falowski, 2015). When looking at
phantom limb pain, in particular, deep brain stimulation in the periventricular grey matter
and the somatosensory thalamus has shown up to a 60% reduction of the pain (Abreu et
al., 2017; Bittar, Otero, Carter, & Aziz, 2005). As with most phantom limb pain
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treatments, these studies have small population sizes, and so further research needs to be
done. With this being said, deep brain stimulation effectiveness in overall chronic pain
and in these small phantom limb studies demonstrates its promise.
As discussed, an invasive technique comes with more associated risk
compared to more conservative measures. While stump revision surgery does not seem
effective in the relief of phantom limb pain (but effective for residual stump pain), deep
brain stimulation could be considered as a promising treatment. Especially in cases where
more conservative treatment has proved unsuccessful.
Mirror Therapy
Much of the research on the treatment options for phantom limb pain discussed
above was conducted with small sample sizes. Additionally, many of these options had
adverse side effects. For this reason, the remainder of this chapter will discuss mirror
therapy, which was introduced earlier in this chapter. Mirror therapy is a non-invasive
treatment option, with very few side effects, that has shown promise in alleviating
phantom limb pain.
Description
In the 1990s, Vilayanur S. Ramachandran invented mirror box therapy, also
known as mirror therapy or virtual reality box therapy. At the beginning of this chapter,
the reader was introduced to the details of Ramachandran’s mirror therapy protocol.
Mirror therapy can be used for both upper and lower limb amputations. Ramachandran’s
account was that of an upper limb amputation. In an upper limb amputation, the patient
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places their affected limb on one side of the box, hidden, while their healthy arm is
placed on the other side. The patient views their healthy arm in a mirror. The patient is
then instructed to move both arms in a symmetrical pattern. The patient views their
“phantom” limb moving by looking at the mirror. The thought is that the brain is
perceiving this mirrored image as the movement of the affected limb, and therefore, it
reduces the pain eliminating what Ramachandran called “learned paralysis”
(Ramachandran & Blakeslee, 1998). Generally, with a lower limb amputation, the same
methods are performed, except a body length mirror and not a box is utilized.
The utility of mirror therapy is not limited to individuals with phantom limb pain
and it has been found to have other uses in stroke and Parkinson’s patients (Bonassi et al.,
2016; Pérez-Cruzado, Merchán-Baeza, González-Sánchez, & Cuesta-Vargas, 2017). In
these disorders, mirror therapy is employed for improvement in movement as well as a
decrease in pain. Mirror therapy has been found to increase the motor recovery and motor
function of upper and lower limb patients affected by stroke (Broderick et al., 2018;
Pérez-Cruzado et al., 2017). Mirror therapy also increases the speed with which
individuals move their limbs in Parkinson’s disease (Bonassi et al., 2016).
In addition to improvement in motor recovery, mirror therapy can improve pain in
their affected limbs. Following a stroke, individuals can develop complex regional pain
disorder in their affected limb. In this disorder, individuals experience a throbbing or
burning pain in the affected limb as well as a decreased pain tolerance in this limb.
Mirror therapy provides an analgesic relief for patients with complex regional pain
disorder. It reduces the pain that individuals experience in their affected limb in both
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intensity and duration (Cacchio, De Blasis, De Blasis, Santilli, & Spacca, 2009). These
uses of mirror therapy reveal that is a promising technique for use in many neurological
disorders.
Effectiveness of Mirror Therapy
Mirror therapy has been shown to be an effective way to relieve phantom limb
pain (Timms & Carus, 2015). Mirror therapy has been shown to reduce the pain intensity
and duration of the pain (Dall et al., 2015; Foell, Bekrater-Bodmann, Diers, & Flor,
2014). In contrast to some of the treatments outlined earlier, the pain relief was shown to
extend through the duration of the treatment (Foell et al., 2014). Multiple external
variables can affect the success of the treatment; for instance, it seems that treatment is
the most successful for individuals who are not using a prosthesis (Barbin, Seetha,
Casillas, Paysant, & Pérennou, 2016). Additionally, it appears that the treatment is the
most successful for individuals who are relieving pain caused by distortional views of
their phantom limb (Barbin et al., 2016). A distortional view of the phantom limb means
that the patient feels as if their limb is twisted in an unnatural manner such as backwards
or warped. It should be noted that mirror therapy does have some side effects, such as a
vague sense of psychological irritation and confusion (Casale et al., 2009),
It should be noted that there has been some critique of the treatment of phantom
limb pain with mirror therapy. While individual studies have demonstrated effectiveness,
as discussed above, review papers point to heterogeneous methods and nonsignificant
relief of pain (Barbin et al., 2016; Timms & Carus, 2015). These studies discuss that
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there are no standardized protocols (such as intensity, length, and duration of treatment)
being studied in relation to mirror therapy, and because of this, its effectiveness cannot be
effectively evaluated. Additionally, the treatment is critiqued due to lack of lasting pain
relief. The relief normally subsides after the treatment concludes (Timms & Carus, 2015).
With this being said, this treatment could be relatively simple for an individual to
continue to perform on their own, in comparison to some of the invasive and
pharmacological treatments discussed earlier.
Another aspect of mirror therapy that needs to be investigated further is agency.
Agency may further explain the discrepancies in treatment pinpointed by the review
papers. Mirror therapy seems to increase the agency that the individual has over their
missing limb and the pain in most cases of treatment (Imaizumi, Asai, & Koyama, 2017).
This increase is most likely due to the congruence of the predicted movement pattern, and
actual sensory feedback that agreed with this prediction. Individuals who feel that they
have control over their affected limb have higher rates of pain relief. This sense of agency
may be a future direction in explaining the incongruence between why mirror therapy
works for some, but not all individuals experiencing phantom limb pain. Another area of
investigation ought to be whether there are extrinsic ways to improve agency in
individuals, or if this is an intrinsic characteristic of the individual.
While it seems that mirror therapy can be an effective mechanism of pain relief
for individuals with phantom limb pain, it does have some side effects. These side effects
are relatively minor compared to other types of treatment discussed in this chapter.
Furthermore, there needs to be more research on what type of protocol works when it
27

comes to mirror therapy. With all this being said, the effectiveness of treatment should be
looked at on a patient by patient (or case by case) basis.
Mechanisms
Like many treatments of phantom limb pain, the mechanisms of mirror therapy
are unclear. One of the main mechanisms that has been proposed for mirror therapy
involves mirror neurons. A mirror neuron is a neuron that fires both when an animal
performs an action and when the animal sees another perform the same action. These
motor neurons were first discovered in the ventral premotor cortex (F5) of the macaque
monkey (Rizzolatti & Craighero, 2004). Some other areas in which mirror neurons have
since been found are the dorsal premotor cortex, parietal cortex, and the primary motor
cortex (Lee et al., 2018). These locations are anatomically connected to the premotor
cortex. As such, it can be seen that the main role of mirror neurons is thought to be the
planning and execution of movement after it has been seen. As such, it has been
hypothesized that mirror neurons have to do with associative learning and it should be
noted that mirror neurons are most likely also involved in somatosensation due to their
existence in the parietal lobe.
In mirror therapy, it is thought that mirror neurons are triggered when the
individual sees the reflection of their limb in the mirror (Finn et al., 2017; Timms &
Carus, 2015). Because of this, the individual then feels the same sensation as if they were
actually moving the limb. The individual does not receive any input from touch receptors
telling them otherwise, as they do not exist. Mirror neurons would then modulate the
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somatosensory inputs being received by the brain, and, for this reason, eventually
decrease the level of phantom limb pain that the individual perceives.
There are some problems with the implications of the involvement of mirror
neurons in mirror therapy. This is due to the fact that mirror neurons are normally thought
to be involved in goal-oriented behavior that involves the hand and/or facial expression.
Specifically, they are thought to be involved in associative learning with these
expressions or movements. These functions do not explain, however, how they would be
involved in movements of other limbs such as the lower limbs, which mirror therapy also
works on. Such conclusions are also due to the fact that most research done on mirror
neurons involve these actions (Ferrari, Gerbella, Coudé, & Rozzi, 2017). Because of this,
further research needs to be done to elucidate whether they are activated with the
movement of other extremities.
Due to the fact that the mirror neuron system is not fully understood, and recently
discovered, it is difficult to understand the system’s full role in mirror therapy.
New Technology
Dr. Ramachandran himself discusses that when he invented the treatment
technique, he could imagine virtual reality systems. In his book Phantoms in the Brain:
Probing the Mysteries of the Human Mind he states, “I thought about virtual reality.
Maybe we could create the visual illusion that the arm was restored and obeying her
commands. But that technology, costing over half a million dollars, would exhaust my
entire research budget with one purchase,” (Ramachandran,1998, p. 46). Recently, virtual
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reality systems have come to the forefront of the research being done to treat phantom
limb pain.
Typically, in a virtual reality set-up, individuals wear a head-mounted display.
Through this display, individuals are shown a mirror-reversed computer graphic image of
an intact arm. This means that they “see” their phantom limb when they look down.
Similar to mirror therapy, individuals are asked to move both their arms in a similar
movement pattern, such as a circle. In a study of eight patients, virtual reality
significantly decreased individuals pain scores (Osumi et al., 2017). Furthermore, a
different study applied tactile stimulation to the same side cheek as the phantom limb, the
intact limb, and a no stimulation control group. Individuals were asked to “touch” objects
that appeared in the virtual reality display. Stimulation was applied through vibration,
similar to that found on a mobile phone. They found that the group where stimulation was
applied to the cheek had the largest reduction in pain compared to the other two groups,
but there was a reduction of pain in all three groups (Ichinose et al., 2017). As described
in Chapter 1, the face and arm areas are near each on the sensory and motor homunculus,
which may help explain why facial stimulation could enhance pain relief (Snyder &
Whitaker, 2013). Via central nervous system plasticity, the areas previously devoted to
the arm may have been encroached upon by the areas devoted to the face, potentially
explaining how cheek stimulation would increase the analgesic effect.
Even with this said, there is isn’t enough research on virtual reality to justify the
investment over mirror therapy at this point. The research on virtual reality systems has
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been on a small study or case study basis. While virtual reality could be a promising area
in the future, at the current time there is not enough research to justify its use.
Conclusion
This chapter shows that there is a wide range of treatments available for phantom
limb pain, yet none are effective for everyone with the disorder. The majority of this
chapter was spent discussing mirror therapy and its potential mechanisms due to the fact
that it is the only treatment for which use was developed originally for phantom limb pain
(Ramachandran & Blakeslee, 1998). For this reason, mirror therapy can be utilized as a
way to further investigate the potential sources of phantom limb pain. Looking forward,
the next chapter will examine the treatments of phantom limb pain described in this
chapter through a bioethical lens.
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CHAPTER 3: BIOMEDICAL ETHICS OF TREATMENT
As discussed in the previous chapters, the treatment of phantom limb pain is very
difficult. Not only are the mechanisms behind phantom limb pain not well understood,
but there is no form of treatment that is effective for everyone. As such, the implications
of treating this disorder must be discussed. This chapter will begin with an overview of
common ethical principles that will guide the discussion of the treatment of phantom
limb pain. The chapter will then outline a framework to guide clinicians through the
treatments of phantom limb pain based on the one provided by Largent (2009) in the
article, “Going off-label without venturing off-course: evidence and ethical off-label
prescribing” to examine the ethicality of phantom limb pain treatments.
Biomedical Ethics Overview
While there are many approaches to biomedical ethics, this chapter will focus on a
dominant approach which centers around four main principles. This approach is called
the common morality principlism and is an effort to resolve issues that arise in clinical
practice. Principles of Biomedical Ethics by Tom Beauchamp and James Childress
(2009) explores these directing principles and their implications. The directing principles
are as follows: principle of respect for autonomy, principle of nonmaleficence, principle
of beneficence, and principle of justice (Beauchamp & Childress, 2009). While
Beauchamp and Childress maintain that these principles are not absolutes, they can be
weighed and balanced in order to create guidelines in clinical decision makings.
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Moreover, these principles are not ranked in any way, but instead, need to be utilized
differently depending on the clinical situation.
Principle of respect for autonomy
Autonomy is generally thought of as a state of self-governance by a group of
people or institution (Autonomy, 2019). The respect for autonomy can be applied to
individuals. Generally, patients should be thought of as independent beings who have the
ability to make their own decisions so long as they are sufficiently autonomous.
Autonomy is arguably the moral basis behind informed consent (Stoljar, 2011). The
elements of informed consent are as follows: (1) the patient must have decision-making
capacity, (2) the patient must receive full disclosure of the treatment, (3) the patient
should understand the treatment, (4) the act must be voluntary, and (5) patient consent
must be obtained (Beauchamp & Childress, 2009).
The principle of autonomy is deeply interwoven with the practice of informed
consent. Informed consent allows practitioners to protect the autonomy of their patients
as well as those who are not autonomous. Individuals must have decision-making
capacity in order to make reasonable treatment options (directed by a physician) for
themselves. If the conditions outlined above are not met, the patient cannot consent to
their treatment.
Principle of nonmaleficence
The principle of nonmaleficence is based on the idea of the Hippocratic oath
which states “do no harm” (Boodt, 2004). In other words, Beauchamp and Childress
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(2009) define this principle as “one ought not to inflict evil or harm” (p. 151). Within a
health care setting, the health care provider has an obligation to refrain from doing any
unjustified harm to the patient. This is known as the harm-benefit ratio. Sometimes, harm
can be associated with the treatment. Practitioners need to have the ability to balance
many moral considerations in order to effectively treat a patient (Beauchamp &
Childress, 2009). Sometimes, the patient and the family of this patient may see the
benefits and risks differently than the practitioner, and for this reason, they need to be
able to see all individuals’ viewpoints.
Principle of beneficence
The principle of beneficence requires that health care providers should promote
good (Beauchamp & Childress, 2009). It refers to the actions that a health care provider
does in order to benefit their patients. One way that beneficence can be demonstrated is
through advocacy for protecting and defending patient’s rights. Practitioners should act in
a way that promotes safety and quality of life for their patients (Chiovitti, 2011).
Furthermore, this principle demonstrates the idea that the health care provider should not
deprive the individual of their harmless pleasures in life. While physicians are not
required to aid these individuals in such pleasures, helping them does fall under the
principle of beneficence (Beauchamp & Childress, 2009).
Principle of justice
In Beauchamp and Childress (2009) Principles of Biomedical Ethics, the authors
do not settle on one definition of justice. They choose to look at justice through multiple
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different theories including utilitarian, libertarian, communitarian, and egalitarian views
of justice. Through examining these theories, they show that no single definition or
theory can sufficiently explore medical policy (Beauchamp & Childress, 2009). While
the previous three principles are more specific to the individual, this principle provides
insight into the treatment of multiple individuals with similar illnesses, the entire
caseload of one provider, or health policy at a national and global level (Kiddell-Monroe,
2014).
Summary
The common morality principlism remains the dominant approach in looking at
clinical practice issues. The four directing principles that Beauchamp and Childress
(2009) developed are the principle of respect for autonomy, the principle of
nonmaleficence, the principle of beneficence, and the principle of justice. These four
principles will guide this chapter’s discussion of the treatment for phantom limb pain.
The Problem of Pain Treatment
Over the last two decades, chronic pain has been recognized as a public health
concern by both people in the medical field as well as the general public (Bostrom, 1997;
Jacox, Carr, & Payne, 1994). Experts are even going so far as to say that the treatment of
pain should be considered a global health priority (Goldberg & McGee, 2011). Severe
and chronic pain is very common. In one study, nearly half of the respondents reported
that they had experienced severe pain at one point in their life (Bostrom, 1997). The
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treatment of all types of pain remains difficult due to the subjective nature of pain (M. P.
Jensen, Karoly, & Braver, 1986).
Even though pain is so common, most of the pain management research studies,
and resulting guidelines, have been for the treatment of cancer pain (Jacox et al., 1994;
Sullivan & Ferrell, 2005). The most common approach to cancer pain is to increase
dosages and different types of medications until pain relief is expressed by the patient
(Jacox et al., 1994). A guideline such as this does not apply to other sources of chronic
pain; conditions as common as lower back pain, or as rare as phantom limb pain. It is not
practical, or safe, for individuals to be on high doses of medications that could impair
their cognitive performance or impact organs for long periods of time (Salvo et al., 2011;
Sukhtankar et al., 2014).
To further demonstrate the problem of pain treatment, the clinicopathological
model of pain should be discussed. In such a model, the physician believes that the
subjective pain an individual is experiencing is due to an objective lesion (Sullivan,
1998). As such, physicians seek out a lesion or disease to explain the pain the patient is
experiencing. Many times, chronic pain does not have an objective cause that physicians
can accurately point to and measure. For instance, imaging may not display a direct cause
to lower back pain that improvements can be quantified from. Because of this lack of
ability to find an objective source of pain, the patient and the physician are both left
feeling unsatisfied about the treatment (Sullivan, 1998). Even when there is an objective
cause for pain, there are still problems with pain treatment. In cancer-related pain, a lack
of pain relief was found when there was a discrepancy between the physician’s and the
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patient’s estimate of the severity of the patient’s pain and its interference with daily
activities (Cleeland et al., 1994). This demonstrates that all types of chronic pain are
subject to inconsistencies during treatment.
Another problem with pain treatment is the scales that are used to evaluate a
patient’s pain. Three common scales are the Visual Analogue Scale, the Verbal Rating
Scale and the Numerical Rating Scale (Williamson & Hoggart, 2005). Each of these
scales asks patients to rate their level of pain as indicated by a mix of verbal and numeric
descriptors. While these scales provide an easy way to assess the pain of the patient, it is
hard for the physician to interpret the scales (Williamson & Hoggart, 2005). These scales
are valid constructs to measure pain, but they do not show the whole picture. These scales
only provide information on the intensity of the pain, not the nature of the pain, or how it
is directly impacting the patient’s life. Additionally, the measurement of pain is
individualized. For example, one patient’s four on the numerical rating scale could be
another person’s seven on this same scale. For these reasons, sometimes the best
measurement of pain is a belief in the patient (McCaffery & Beebe, 1989).
Making pain treatment even more complex, a large amount of a patient’s
relationship to their pain is subjective. Not only does the perceived pain vary from person
to person, as discussed earlier, but the intensity can also be altered due to perceived
damage that the pain might cause to the individual (Arntz & Claassens, 2004). This
means that if the individual believes the pain is associated with tissue damage (such as in
cancer) they tend to perceive and rate the intensity of the pain higher (Arntz & Claassens,
2004). Additionally, the intensity of a patient’s pain can change due to the meaning of the
37

pain to the individual (Arntz & Claassens, 2004). Meaning can be altered by the emotions
that the individual has toward the pain such as with traumatic events associated with the
pain (Ravn, Vaegter, Cardel, & Andersen, 2018). To make things even more complex,
with most chronic pain, there is a high comorbidity of depression and other mental illness
(Benjamin, Barnes, Berger, Clarke, & Jeacock, 1988). Such comorbidity with mental
illnesses, such as depression, is thought to be due to neurobiological components shared
between the two, such as a reduced level of serotonin (Boakye et al., 2016). The way that
the individual perceives pain can be influenced by their mental health, as well as how the
pain is presented to them.
When we turn to look at phantom limb pain, it can be seen why the measurement
and treatment of this pain is so difficult. First, there is no physical evidence of the pain
when the cause is phantom limb pain. These patients have an objective lesion when
looking at their amputation, but this lesion only explains stump pain. Second, as
discussed in Chapter 1, the mechanisms behind this pain are not understood (L.
Nikolajsen & Jensen, 2001; Richardson, 2010; Stockburger et al., 2016). Third, many of
the patients that experience phantom limb have had traumatic events that may lead to
alterations in the way they view their pain (Cavanagh, Shin, Karamouz, & Rauch, 2006;
Desmond & MacLachlan, 2006). Fourth, just as with other types of pain, there does not
seem to be an objective measurement for the phantom limb pain.
Phantom limb pain is just a small subset of the pain disorders that need to be
discussed, but it will remain the focus of this chapter. Choosing the correct treatment for
phantom limb pain is difficult for physicians, as no one treatment exists to cure the pain.
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For this reason, this chapter will provide a framework modified from “Going off-label
without venturing off-course: evidence and ethical off-label prescribing” by Emily
Largent (2009) in order to weigh the risk and benefits of the common treatments
described in the previous chapter to better help clinicians evaluate different treatments for
phantom limb pain.
Biomedical Ethics in Phantom Limb Pain
Framework Provided in “Going off-label without venturing off-course: evidence
and ethical off-label prescribing” by Largent (2009)
In Largent’s (2009) article, she examines how clinicians should prescribe offlabel drugs. Largent (2009) creates these guidelines because there is “very little guidance
to distinguish clearly between off-label uses that are well supported by evidence and
those that are not,” (p. 1745). An on-label use of a drug is the utilization of a drug for its
FDA approved purpose (Aronson & Ferner, 2017). Off-label use is one in which the drug
is not being used for its approved labeling use (Largent, 2009). While the off-label drug
has already obtained FDA approval, it is being used outside of its approved use. For
example, this would be a drug that is approved to treat breast cancer (on-label use) but is
used by a physician to treat lung cancer (off-label use). Off-label drugs present a number
of practical and ethical issues for physicians because they are often used with a very
limited amount of information about their efficacy in the conditions for which they have
not been approved. Practically speaking, strict clinical guidelines are given for a drug
when it is being used on-label. For example, in on-label use, side effects can be easily
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identified and discussed with the patient. On the contrary, when a drug is being used offlabel, new adverse side effects may arise when being used in a new disorder. Further
ethical issues come forth with off-label use because clinicians must decide how much
information to disclose to their patient about off-label uses. For these reasons, Largent
(2009) develops a framework in order to aid physicians in the clinical decision-making
process when using off-label drugs.
Signals for scrutiny.
There are four categories that the article presents in order to signify more rigorous
scrutiny of the off-label use which include (1) New Drugs, (2) Novel Off-Label Use, (3)
Drugs with Known Serious Adverse Effects, and (4) High-Cost Drugs (Largent, 2009).
These characteristics are outlined in more detail below:
(1) New Drugs: These are drugs that have been approved by the FDA, but have
been on the market fewer than 3-5 years. Drugs such as this have few clinical trials and
high-quality studies proving if they work. Additionally, it is only after many years on the
market that all the adverse side effects are seen, especially those that result from the longterm use of a drug.
(2) Novel Off-label Use: This is a new or unusual use for an FDA approved drug.
This is dissimilar to the cancer example provided above because in that example the drug
was being used for similar treatment, another form of cancer. Novel off-label use refers to
a new use of the drug that might be on its own, or in combination with others, in which
unknown side effects are likely to arise. For example, a drug in this category may have
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been FDA approved for high blood pressure, but is being used off-label for an unrelated
condition such as multiple sclerosis.
(3) Drugs with Known Serious Adverse Effects: These drugs need to be strictly
monitored because they have a large risk of serious adverse side effects. While these
drugs might be justified, dependent on the disorder, most of the time their risk outweighs
their benefit.
(4) High-Cost Drugs: These drugs are expensive in terms of monetary value.
While they might be highly effective in off-label use, they would be costly to the patient.
These signals of scrutiny should be used in order to demonstrate that the off-label
prescription of these drugs needs further investigation.
Evidentiary categories.
Further investigation of these drugs should be done by examining the evidence of
their net benefit. Largent (2009) outlines evidentiary categories and the recommendation
for prescription provided in the chart below:
Table 1
Therapeutic Consent Recommendation based on Evidentiary Category
Category
Evidence
Recommendation
Supported
Moderate-high level of certainty
Routine therapeutic
of net health benefit
consent
Suppositional

Low level of certainty of net
health benefit

Augmented therapeutic
consent

Investigational

Very low level of certainty of net
health benefit

Clinical trial/research only
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Supported.
In this category, there is evidence from high-quality studies that the drug will
have an increase in net health benefit. In other words, there is a large number of potential
benefits as compared to potential harms. The potential harms and benefits of these drugs
are supported by high-quality studies. For example, within these studies, there is a large
number of participants and randomized control (Sawaya, Guirguis-Blake, LeFevre,
Harris, & Petitti, 2007). Largent (2009) recommends that routine therapeutic consent be
done when prescribing this drug. In other words, the consent process should be treated as
if it was of on-label use. The processes of informed consent that were discussed at the
beginning of this chapter should be followed.
Suppositional.
This category has a low level of certainty of net benefit. This could be because of
a higher potential for harm than benefit from the drug. It could also be because the drug’s
efficiency is not well supported by high-quality studies. Suppositional evidence requires
what Largent calls augmented therapeutic consent (2009). While the components of
informed consent remain, there should be more disclosure than commonly provided when
prescribing an on-label drug. Furthermore, the physician should communicate the
uncertainties in terms of both potential risks and potential benefits. This type of
disclosure should allow more room for the patients’ beliefs.
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Investigational.
In this category, there is a very low certainty of net benefit. This means there is
high risk associated with the drug, with low benefit, as well as very little evidence to
support its use. In other words, a physician should prescribe this drug under research
protocols only. She argues that these drugs require the formality of written informed
consent (Largent, 2009).
Framework for Phantom Limb Pain
Largent’s framework provides a place to start when discussing the treatment of
phantom limb pain. While Largent’s framework is dealing with off-label drug use, I
argue that her framework can be helpful for the treatment phantom limb pain because
none of the treatments for phantom limb pain are FDA approved specifically for use in
the phantom limb. Furthermore, currently, there is limited research and evidence that
support these treatments’ use in phantom limb pain. The evidentiary categories that she
provides will be the focus in the discussion of the treatment of phantom limb pain, as
each of the treatments discussed in chapter two will be placed in one of the categories.
With this being said, there are cases when the signals for scrutiny will also find their way
into the discussion.
The first change that will be made is no longer will the discussion be limited to
that of off-label drug use. Instead, this discussion will be expanded to all treatments
available for phantom limb pain. Treatments, just like drugs, have potential benefits as
well as potential harms associated with them. All treatments available for phantom limb
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pain are off-label use because none of them are FDA approved. Moreover, these
treatments were not originally designed for the treatment of phantom limb pain (with the
exception of mirror therapy), but for other forms of chronic pain (such as with opioids) or
other disorders that do not involve pain (such as antidepressants).
Another change that will be made from Largent’s evidentiary categories is the
expansion of the suppositional category. As the discussion progresses, it will be argued
that the majority of phantom limb treatments fall into this category due to the low level of
support present for the treatments. The following chart below will be used to evaluate
these treatments:
Table 2
Order of Use in Suppositional Category Based on Cost and Risk
Level of Risk
Level of Cost
Order of Use
Low Risk

Low Cost

1st Line

Low Risk

High Cost

2nd Line

High Risk

Low Cost

3rd Line

High Risk

High Cost

4th Line

In what follows, I will present a clinical tool for practitioners to help them
navigate these treatment options with their patients. The order of use is the order in
which the treatment options should be presented to their patients. The first line are those
treatments that should be prescribed and tried first, the second line should be prescribed
second and so on. The categories of risk and cost are chosen to further evaluate these
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treatments due to the bioethical principles discussed at the beginning of this chapter. I
argue that risk needs to be evaluated due to the principle of nonmaleficence. Physicians
should be prescribing drugs first that do not harm the patient. Additionally, cost needs to
be evaluated due to the principle of beneficence and the principle of justice. The
physician ought to provide the least costly treatment first in order for more patients to
have access to treatment. Moreover, by examining cost, the physician is taking into
account the other financial responsibilities that the patient may have to themselves or to
their families. Another reason this framework examines cost because high cost is also one
of the signals for scrutiny that Largent (2009) provides for off-label use.
Phantom Limb Pain Treatments
Below, I fill in the charts provided in accordance with the types of treatments that
are available for phantom limb pain. Even though clarifications for the rankings will be
provided, chapter two should be referred to for more in-depth descriptions and studies of
the treatments. It should also be noted that while not all categories are filled in, it is
important for them to be present in case a new treatment becomes available.
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Evidence Labels.
Table 3
Phantom Limb Treatments Placed in Evidentiary Categories
Evidentiary Categories
Treatments
Supported
None

Suppositional

Mirror Therapy
Opioids
NMDA Receptor Antagonists
NSAIDs
Acetaminophen
TENS Unit
Spinal Cord Stimulation
Bupivacaine

Investigational

Anticonvulsants
Antidepressants
Acupuncture
Botulinum toxin type A
Lidocaine
Spinal Cord Stimulation
Stump Revision
Deep Brain Stimulation

At the current time, no treatment exists for phantom limb pain that falls under the
supported category. This is because, currently, all of the research done on the treatment
of phantom limb pain includes small numbers of participants, case studies, and
conflicting evidence (Alviar et al., 2016; Ehde et al., 2000; Pérez-Cruzado et al., 2017).
For this reason, no treatments have a moderate to a high degree of certainty of net benefit.
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In terms of the investigational category, anticonvulsants, antidepressants,
acupuncture, botulinum toxin type A, and lidocaine have all been placed category due to
their conflicting research and limited support for pain relief (Alviar et al., 2016; Bone et
al., 2002; Trevelyan et al., 2016; H. Wu et al., 2012). Additionally, drugs such as
anticonvulsants and antidepressants fall under the novel off-label use category because
their approved labeling is not involved in pain management (Bone et al., 2002; Hall,
Carroll, & McQuay, 2008).
Looking further into the investigational category, stump revision, spinal cord
stimulation, and deep brain stimulation have been placed here due to their high potential
for harm and low potential for net benefit. Additionally, all three of these treatments are
surgical, and thus are high in cost (Bell, Mathieu, & Racine, 2009). Due to this high cost,
they fall under the signal for scrutiny of drugs (or treatments). Additionally, surgical
treatments have known adverse side effects. Stump revision surgery is successful in
relieving stump pain by removing neuromas and other causes of the pain but sees very
little success in the relief of phantom limb pain (Tintle et al., 2012). As with any surgery,
there can be adverse side effects in the way of various complications including infection,
blood clots, reaction to anesthesia, and many others (Tintle et al., 2012). Spinal cord and
deep brain stimulation have a large degree of potential harm for these same reasons with
the additional confound that they involve implantation of an electrode in the brain or
spinal cord (Abreu et al., 2017; Maslen et al., 2018; Viswanathan et al., 2010). Each of
these is not well researched in terms of phantom limb pain but has been successful in the
relief of other types of chronic pain (Farrell et al., 2018; Smits et al., 2013). For these
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reasons, I argue that these treatments should be reserved for prescription after the
suppositional categories have failed to treat the patient’s symptoms and these treatments
should be performed in a research setting only.
Suppositional Expanded.
Table 4
Suppositional Treatments for Phantom Limb Pain in Order of Use
Order of Use
Treatments
1st
Mirror Therapy
TENS unit
2nd

NMDA Receptor Antagonists
NSAIDs
Acetaminophen

3rd

None

4th

Bupivacaine
Opioids

The treatments that I have placed in this category span a wide range of options
from medication to injections or physical therapy. In general, these are the most
commonly used treatments for phantom limb pain, and for these reasons they have the
most research available. However, most of the indicators are not from randomized or
double-blind trials, but rather patient surveys (Baron, Wasner, & Lindner, 1998; L.
Nikolajsen & Jensen, 2001).
Starting from the bottom and looking at the fourth line of use, both an injection
and opioids are fairly expensive, especially if the patient does not have insurance (Zezza
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& Bachhuber, 2018). Bupivacaine requires a professional for the injection, and opioids
require a lifetime prescription. Additionally, these medications have a relatively high
potential for harm as compared to others in the suppositional category. For example,
bupivacaine can cause permanent numbing if injected wrong (Nikolajsen, Ilkjaer,
Christensen, Krøner, & Jensen, 1997). For opioids, they have numerous adverse side
effects including addiction, dizziness, nausea, etc. (Wilder et al., 2016).
Currently, there are no treatments in the third line of prescription which are high
risk and low cost. Moving up to the second line of use, many of the common
prescriptions for phantom limb pain can be found including NSAIDs and acetaminophen
(Stockburger et al., 2016). Low-cost versions of these drugs can be found over the
counter placing them into this category. In terms of risk, both drugs have potential harms
such as liver failure, gastrointestinal and cardiovascular problems (Hanley et al., 2006;
Salvo et al., 2011).
The two treatments that fall into the low risk and low-cost category are
transcutaneous electrical nerve (TENS) units and mirror therapy. These two treatments
have some research demonstrating their ability to decrease phantom limb pain (Tilak et
al., 2016). Additionally, after being taught how to perform mirror therapy or how to use a
TENS unit by a physical therapist, the individual can perform the therapy whenever they
want with little cost to them (Mulvey et al., 2010; Pérez-Cruzado et al., 2017). One
differentiating factor between the two treatments is that TENS unit alleviates the pain for
only a short duration (hours), while mirror therapy has some potential for its effect to last
longer (days; Casale et al., 2009; Köke et al., 2004)
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What This Means for the Prescription of Treatment
In the midst of not understanding the mechanisms behind phantom limb pain,
medications have found themselves at the forefront of pain treatment (Stockburger et al.,
2016). As we return to biomedical ethics principles, increased prescription of in pain
medication (often in increasing dosage) in those with phantom limb pain prior to trying
less risky alternatives goes against the principle of nonmaleficence. In these cases, the
health care provider is potentially doing the patient more harm than good when there are
other options available.
The previous chapter went into great depth on the treatment of phantom limb pain
with mirror therapy. It can be seen from the framework provided why this is so. For one,
mirror therapy is relatively inexpensive. While mirror therapy must be done with a
physical therapist for a few sessions, after learning how, a patient can perform the
technique by themselves. If effective, this decreases the cost of the treatment compared to
other traditionally prescribed options such as opioids. As such, mirror therapy follows the
principle of beneficence in treatment. If the treatment is successful, they can return to
their daily activities with very little monetary cost to them and avoid the risky side effects
of opioids such as addiction, nausea, etc. Furthermore, this increases the number of
individuals who have access to the treatment, and for this reason, follows the principle of
justice.
Looking further into the principle of justice, these individuals are often from a
vulnerable population. As discussed earlier, mental illness is frequently comorbid with
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chronic pain (Benjamin et al., 1988). Furthermore, those with phantom limb pain are
even more vulnerable due to the fact that their pain can be associated with a traumatic
event (Cavanagh et al., 2006; Desmond & MacLachlan, 2006). Prescription of opioids
could make their condition worse if they are suffering from post-traumatic stress disorder
or depression (K. Z. Smith, Smith, Cercone, McKee, & Homish, 2016). Because of this,
treatments with less risk associated with them should be considered first when looking at
the phantom limb population.
While I have argued for low-risk and low-cost treatment options to be presented
and discussed with the patient first, just like in Largent’s (2009) framework, I maintain
that the choice should be up to the patient. The framework that is provided is one that
clinicians can turn to when prescribing treatment for phantom limb pain. I maintain that
the treatments should be presented in the order described by the framework, but the
framework should not be the only viewpoint that the clinician should examine. In other
words, the clinician should consider the patient’s opinions when making treatment
decisions. This is based on the principle of respect for autonomy. As described earlier,
the patient understands their pain and their own risk aversion better than anyone else
(McCaffery & Beebe, 1989).
Phantom limb pain, and is treatments are not well understood, and the patient
should understand this concept. Because all of the treatments available for phantom limb
pain currently fall in the suppositional category, a clinician should have a conversation
with the patient that discloses all the risks and benefits of the treatment being provided.
The patient should work with the physician to recognize the harm-benefit ratio for any
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treatment. This ratio, which falls under the principle of nonmaleficence, may be weighed
differently in the patient’s eyes. If the patient decides they want to take a more drastic
approach, due to the intensity of their pain or some other reason, similar discussions
should take place as they move down the lines of treatment. In order to ensure the patient
receives this type of treatment plan, a further recommendation of a team-based approach
to treatment needs to be discussed.
Practical Recommendation
To ensure that patients receive information about multiple treatments and
understand the harm-benefit ratio of each, more voices should be brought into the
treatment of phantom limb pain. While cancer pain and phantom limb pain are two very
different types of pain, as discussed earlier, they are both subjective experiences which
are similar in the fact that they are both complex in their mechanisms and treatment (L.
Nikolajsen & Jensen, 2001; Robb et al., 2010). For this reason, this section will use one
of the guidelines put forth by cancer pain treatment that could aid in the treatment of
phantom limb pain.
Team-Based Approach
One guideline set forth for cancer-related pain, but seems to be lost in the
treatment of phantom limb pain, is “a collaborative, interdisciplinary approach to the care
of patients” (Jacox et al., 1994, p. 651). With this collaborative approach, an
individualized treatment plan for the patient can be created. The patient can be actively
engaged in their treatment plan because they are thought of as a member of the team. For
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the purposes of this discussion, it can be assumed that most individuals with phantom
limb pain meet the criteria discussed above for informed consent. This is due to the fact
that most of these patients’ comorbidities with amputations are of a physical nature
(Foote et al., 2015; Wukich & Pearson, 2013). For this reason, this approach to treatment
increases the autonomy a patient has throughout their treatment. A patient receiving
treatment for cancer pain has not only an oncologist on their team, but a pharmacologist,
physical/occupational therapist, and psychiatrist/psychologist. Similar to this cancer
guideline, this approach is currently being expanded to the treatment of other chronic
pain disorders (Gatchel, McGeary, McGeary, & Lippe, 2014). In the treatment of
phantom limb pain, I believe that there are two key voices that are not present: a
psychologist and a physical therapist. These two core positions can increase the principle
of beneficence in these patient’s care. Both positions serve as key advocates for patient
safety and wellbeing.
Psychologist/Psychiatrist
I recommend a psychologist/psychiatrist joining the team due to the likelihood of
patients developing a mental illness while experiencing phantom limb pain (Ahmed et al.,
2017). In the interdisciplinary team, a psychologist’s role is to “provide a full
psychosocial evaluation” and “Assess [the] patient’s psychological strengths and
weaknesses” (Gatchel et al., 2014, p. 124). In doing so, the psychologist is examining the
mental health of the individual and helping them through any mental illnesses they may
have. In regards to patients with phantom limb pain, there is an increased prevalence of
depression that should be addressed by a psychiatrist (Ahmed et al., 2017). Specifically,
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body image and decreased self-esteem in these patients could play a role in this
depression for individuals (Atay, Turgay, & Atay, 2014). While this particular article by
Atay, Turgay, and Atay (2014) finds the relationship between decreased self-esteem and
depression with individuals using a prosthesis, it can be assumed that there is a similarity
without prosthesis use. Because pain interpretation is, in part, emotionally based, and due
to the high comorbidity of depression, phantom limb pain patients should have a
psychologist/psychiatrist on their team as well.
Physical Therapist
I recommend a physical therapist to join the team in the treatment of phantom
limb pain. While physical therapists are commonly utilized in the treatment of amputees
during prosthesis training, they should further provide a role in pain management (Cole,
2003). It should be noted that phantom limb pain is not the only pain experienced by
patients after an amputation. They can also experience stump pain, which is coming from
amputation (T. S. Jensen et al., 1983). A physical therapist can encourage the treatment
of these pains through noninvasive techniques. Some techniques that could be suggested
include a transcutaneous electrical nerve stimulation (TENS) unit or mirror therapy
(Tilak et al., 2016). These treatments provide an alternative for any patient, but
particularly those who do not want to become dependent on medications or endure drastic
measures for the alleviation of their pain.
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Summary
In implementing a team-based approach to treatment, the respect for autonomy for
the patient in their treatment will be increased. The voices of a psychologist/psychiatrist
and a physical therapist will provide better treatment for phantom limb pain. These voices
will aid in providing different explanations for the reasons behind the pain, as well as
treatment options beyond the medications commonly provided. As such, the patient will
have a more positive and ethically informed treatment experience.
Conclusion
This chapter began with introducing common morality principlism, which served
as an introduction to bioethical theory. The chapter then introduced the problem with pain
treatment in general but narrowed down on the specifics of phantom limb pain treatment.
In order to examine the treatments that exist, and the treatments that may come forth, a
framework based on the framework presented in “Going off-label without venturing offcourse: evidence and ethical off-label prescribing” by Largent (2009) was presented.
This, in conjunction with common morality principlism, allowed the ethical evaluation of
the treatments available for phantom limb pain. While this is just one way to examine
phantom limb pain, it provides a framework to help guide clinicians through the
treatments of phantom limb pain. This framework argues that the first treatment that
should be presented to a patient is that of mirror therapy, with other noninvasive
treatments and medications to be presented subsequently. With this being said, the
framework is just a tool, and the choice should be ultimately up to the patient. This
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evaluation of treatment further highlighted the need for an interdisciplinary team,
including a psychologist/psychiatrist and physical therapist in order to effectively treat
this complex disorder.
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CONCLUSION AND REFLECTIONS
As we look forward from this exploration of phantom limb pain and its treatment,
I would like to make some concluding remarks. First, I would like to explore what I see
as a potential cause of phantom limb pain and how this could be examined in a research
setting. Secondly, I would like to broaden what the treatment of phantom limb pain
means for the investigation and treatment of other disorders. In particular, I would like to
explore how this thesis has changed the way I think of treatment as I soon approach the
next portion of my education, pursuing my degree as a Doctor of Physical Therapy.
The Visual Side of Phantom Limb Pain
In his book Phantoms In The Brain, Ramachandran (1996) discusses the impact
of visual feedback on phantom limb pain. Ramachandran explains that the brain is
sending out signals for the amputated limb to move, but the brain does not receive any
sensory or visual feedback that the arm is actually moving. After this repeated signaling
the brain comes to a state of “learned paralysis” as the inability to move is “stamped onto
the brain’s circuitry” (Ramachandran & Blakeslee, 1998, p. 46). In other words, the brain
creates a memory that this limb is immobile. Ramachandran then proposes mirror therapy
as a way to “trick [the] eyes into actually seeing a phantom,” (Ramachandran &
Blakeslee, 1998, p. 46). While Ramachandran mostly abandons the talk of the impact of
the visual system and returns to the theory of remapping and maladaptive plasticity, I
believe he may be missing a key component to phantom limb pain.
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While the theories present for phantom limb pain presented in Chapter 2 are
backed by support, none of them tell the whole story. Furthermore, they do not fully
explain why mirror therapy serves as an effective treatment (Young Kim & Young Kim,
2012). In examining the relief that mirror therapy provides, it does induce changes in the
somatosensory cortex after four weeks of treatment (Foell et al., 2014). As such, when
mirror therapy is applied there is a reduction between the asymmetry of the two
hemispheres. This change supports the theory of central nervous system maladaptive
plasticity because these changes correlate with phantom limb pain reduction. It does not,
however, explain the instantaneous relief that some patients receive from mirror therapy
after one session. Ramachandran describes that the “digging sensation” in one individual
was eliminated during his first time using the mirror (Ramachandran & Blakeslee, 1998,
p. 53). Additionally, this same relief in phantom limb pain is seen after five sessions or
one week of treatment (Chan et al., 2007; Finn et al., 2017). For this reason, the visual
system’s impact and the conflicting signals the brain is receiving while experiencing
phantom limb should be expanded upon.
One such example can be found in the theories behind motion sickness. One
proposed explanation for motion sickness is called sensory conflict theory. This theory
proposes that a mismatch is occurring between the visual and vestibular sensations in
regards to the experience of motion (Kohl, 1983). For example, when an individual is
reading a book in a car. Their eyes are not sensing movement, but their vestibular system
is sensing the forward movement of the car. Further investigations of motion sickness
have supported the role of both systems in the disorder (Ishak, Bubka, & Bonato, 2018;
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Warwick-Evans, Symons, Fitch, & Burrows, 1998). Due to this mismatch, the individual
experiences nausea, lethargy, and other symptoms of motion sickness.
I propose a theory that phantom limb pain may have a similar sensory conflict
with slightly different systems. While the conflict is still due to a visual system mismatch,
the mismatch occurs with somatosensory information. The brain does not “see” an arm,
like Ramachandran discusses, but is still receiving somatosensory input. This
somatosensory input could be in the form maladaptive plasticity in the central nervous
system or input from severed peripheral nervous system fibers. One way to investigate
this hypothesis would be to explore whether there is a reduced frequency, or decreased
intensity, of phantom limb pain in patients that are blind. While this may seem like a
small portion of individuals, blindness and amputations are both complications of
diabetes and perhaps likely of various forms of war trauma such as with IED explosions.
This component of phantom limb pain does not discount the other theories developed;
instead, it adds to the discussion of other confounding factors that could influence pain.
While developing an experiment is outside the scope of this thesis, these factors warrant
further research.
Expanding Outward
As I hope this thesis has demonstrated, phantom limb pain is a difficult disorder
to understand and treat. This difficulty is not just felt by those attempting to research and
treat the disorder, but by those who experience it. These individuals are who this thesis
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intends to benefit. At this time, I would like to demonstrate the difficulty that phantom
limb pain brings to individuals through some quotations.
In an article by Nortvedt and Engelsrud (2014), the authors record the words and
capture pain felt by individuals who have lost a limb. One man who lost his arm to a
motorcycle accident describes his excruciating phantom limb pain as such:
It’s as if the skin of my arm has been ripped off; salt is being poured on it and
then it’s thrust into fire. I also sometimes feel as if the fingers on my amputated
hand are moving uncontrollably, which is both extremely painful and
embarrassing (Nortvedt & Engelsrud, 2014, p. 602).
It is hard for any of us to imagine dealing with that kind of pain on a day-to-day basis.
While this is just one description, it provides an example of the intensity of pain that
these individuals feel while experiencing phantom limb pain. A type of pain that no scale
nor physician could begin to understand.
In the same article, a man addresses his depression that results from phantom limb pain:
It’s constant as if I have a big, strange object growing out on my head that I can’t
get rid of. It’s always there and it drives me crazy. It does something terrible to
me. I can’t concentrate on anything but the pain. If I read a book I can’t
concentrate on the text and I don’t remember what I’ve read. I can’t go on living
like this (Nortvedt & Engelsrud, 2014, p. 604).
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This quote is striking in that it really puts into context how the pain can affect these
individuals’ lives. An everyday activity, such as reading, can be impaired by phantom
limb pain. This debilitation, among other factors, leads to depression in these individuals
(Ephraim, Wegener, MacKenzie, Dillingham, & Pezzin, 2005). This is why examining
the pain, and looking for the best way to treat it, is so important for these individuals.
Moreover, the ideas presented in these quotations expand further than just
phantom limb pain, but to others who experience other debilitating chronic pain
disorders. Fibromyalgia, complex regional pain syndrome, migraines, dystonia, and
restless leg syndrome are just a sampling of disorders, similar to phantom limb pain,
where the cause is unknown and the treatment is complex and riddled with an array of
pain killers (Buse et al., 2012; Garcia-Borreguero, Cano-Pumarega, & Marulanda, 2018;
Mackey & Feinberg, 2007; Painter & Crofford, 2013; Srinivasan, Lim, & Thirugnanam,
2007). Similar to phantom limb pain, the chronic pain in these disorders can become
debilitating to the individual’s life.
Because of this, I hope that this thesis brought forth the idea that more research
should be done into both the mechanisms and treatments of phantom limb pain and
related disorders. While it is important to look at and examine further treatments of these
disorders, I believe that more focus needs to be put on the mechanisms of phantom limb
pain and related disorders. In doing so, the similarities and differences between chronic
pain disorders can be discovered. From there, more individualized treatment plans for
these disorders can be formalized. Because, as seen with the case of phantom limb pain,
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treatments such as opioids and NSAIDs that work well in relieving many types of pain,
do not work well when it comes to this disorder.
I also hope that my thesis brings forth a framework for treatment that can be
utilized by clinicians when treating phantom limb pain, and other disorders where there is
limited research on the mechanisms and treatment of the disorder. This thesis began as an
exploration of the interaction between phantom limb pain and mirror therapy and ended
with me discovering that I believe it truly should be the first place that treatment should
start. Through this thesis, I found that physicians often prescribe medications with
multiple side effects as a way to help alleviate the pain, even though there is little
research to support them. This is true despite the fact that minimally invasive, low-cost
treatments, like mirror therapy, are available that have similar degrees of support as the
medications.
This thesis has illuminated for me the complexities that arise when examining
how to treat a patient. While I understand it has only scratched the surface of these
difficulties, it has shown me how to begin to weigh the pros and cons of various
treatments when limited information is available. As a future physical therapist, I hope to
become an advocate for patients with disorders, such as phantom limb pain, that are not
well understood. As such, I hope to endorse and advance the noninvasive treatment
options that my future occupation has to offer.
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